Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Minerva Neuroscie
(NQ:
NERV
)
3.180
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Minerva Neuroscie
< Previous
1
2
3
4
5
6
Next >
5 Short Squeeze Stocks That Could Soar: NeruoBo Pharmaceuticals, FaZe Holdings And More
September 19, 2022
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates for the week...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 14, 2022
Gainers Enochian BioSciences (NASDAQ:ENOB) shares moved upwards by 27.8% to $2.3 during Wednesday's after-market session. The market value of their outstanding shares is at $121.7 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 31, 2022
Via
Benzinga
Short Interest Sector Focus: Healthcare Sector
August 30, 2022
As of the close of business on Monday, 8/29, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...
Via
Benzinga
Minerva Seeks FDA Approval For Its Schizophrenia Candidate
August 22, 2022
Via
Benzinga
Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday
September 01, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 29, 2022
Via
Benzinga
Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday
August 30, 2022
Gainers
Via
Benzinga
Dow, Nasdaq Off Triple Digits As Market Rout Deepens
August 29, 2022
The selloff among stocks is deepening as Fed Chairman's jarring Jackson Hole speech continues to send waves through Wall Street.
Via
Talk Markets
Why Chimerix Is Trading Higher By Over 19%, Here Are 53 Stocks Moving In Monday's Mid-Day Session
August 29, 2022
Gainers Advanced Human Imaging Limited (NASDAQ: AHI) shares jumped 53% to $1.04. Advanced Human Imaging announced Sunday it signed a Master Services Agreement with Estonia-based Activate Health OÜ.
Via
Benzinga
Pinduoduo, JinkoSolar And Some Other Big Stocks Moving Higher On Monday
August 29, 2022
Minerva Neurosciences, Inc. (NASDAQ: NERV) jumped 25% to $12.96. Point72 Asset Management recently reported an 8.8% passive stake in the company.
Via
Benzinga
Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday
August 29, 2022
Gainers Micro Focus International plc (NYSE: MFGP) shares surged 92% to close at $6.01 on Friday after the company reached an agreement with OpenText to be acquired for $6 billion.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 26, 2022
Via
Benzinga
Why Several Chinese Stocks Traded Higher; Here Are 58 Biggest Movers From Yesterday
August 26, 2022
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) surged 95.3% to close at $0.2580 on Thursday after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a price target...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
August 25, 2022
Via
Benzinga
Why Snowflake Is Trading Higher By 20%, Here Are 51 Stocks Moving In Thursday's Mid-Day Session
August 25, 2022
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 91% to $0.2530 after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a price target of $6.50.
Via
Benzinga
US Stocks Open Higher; Dow Rises Over 100 Points
August 25, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 25, 2022
Via
Benzinga
Why Minerva Neurosciences Shares Traded Higher By Over 66%; Here Are 78 Biggest Movers From Yesterday
August 25, 2022
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) shares gained 66.5% to close at $7.51 after Point72 Asset Management reported an 8.8% passive stake in the company.
Via
Benzinga
Billionaire Steven Cohen Just Made a Big Bet on Minerva Neurosciences (NERV) Stock
August 24, 2022
Shares of NERV stock are exploding higher following a significant purchase by Point72's Steve Cohen and the submission of an NDA.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 24, 2022
Via
Benzinga
Why Citi Trends Is Trading Lower By 17%, Here Are 47 Stocks Moving In Wednesday's Mid-Day Session
August 24, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 77% to $2.35. Bright Minds priced overnight marketed offering of 2.858 million units at $1.40 per unit.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 24, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
August 24, 2022
It's time to start the day with a breakdown of the biggest pre-market stock movers for Wednesday and the news moving those shares.
Via
InvestorPlace
Why Bed Bath & Beyond Is Trading Higher By 12%; Here Are 26 Stocks Moving Premarket
August 24, 2022
Gainers Bird Global, Inc. (NYSE: BRDS) shares rose 25.2% to $0.54 in pre-market trading. Bird secured permit extensions and expanded to new U.S. cities.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 23, 2022
Gainers
Via
Benzinga
Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday
August 23, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of...
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 22, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 22, 2022
Via
Benzinga
Minerva Seeks FDA Approval For Schizophrenia Candidate
August 22, 2022
Minerva Neurosciences (NASDAQ: NERV) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for roluperidone in the treatment of negative symptoms for patients with...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.